title: Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis.
authors.affiliation: Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Amaya L
authors.initials: AL
authors.lastname: Bustinduy
authors.affiliation: Center for International Health Research, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
authors.forename: Jennifer F
authors.initials: JF
authors.lastname: Friedman
authors.affiliation: Norwegian Centre for Imported and Tropical Diseases, Department of Infectious Diseases Ullevaal, Oslo University Hospital, Oslo, Norway.|Discipline of Public Health Medicine, Nelson R. Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
authors.forename: Eyrun Floerecke
authors.initials: EF
authors.lastname: Kjetland
authors.affiliation: Department of Epidemiology and Biostatistics University of Georgia, Athens, Georgia, United States of America.
authors.forename: Amara E
authors.initials: AE
authors.lastname: Ezeamama
authors.affiliation: Schistosomiasis Control Initiative, Imperial College London, London, United Kingdom.
authors.forename: Narcis B
authors.initials: NB
authors.lastname: Kabatereine
authors.affiliation: Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
authors.forename: J Russell
authors.initials: JR
authors.lastname: Stothard
authors.affiliation: Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, United States of America.
authors.forename: Charles H
authors.initials: CH
authors.lastname: King